Roche’s Alecensa gets green light for early access scheme

4th September 2017 Uncategorised 0

UK patients with a rare form of lung cancer will be able to access Roche’s Alecensa without the need for prior chemotherapy before official approval is obtained, following its inclusion in the country’s Early Access to Medicines Scheme.

More: Roche’s Alecensa gets green light for early access scheme
Source: News